Stockholm - Delayed Quote SEK

Annexin Pharmaceuticals AB (publ) (ANNX.ST)

33.00
0.00
(0.00%)
At close: 5:29:38 PM GMT+2
Currency in SEK All numbers in thousands
Download
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
0
0
0
0
0
Operating Expense
46,036
50,397
44,039
40,656
52,826
Operating Income
-46,036
-50,397
-44,039
-40,656
-52,826
Net Non Operating Interest Income Expense
230
229
122
-2
-1,859
Pretax Income
-45,767
-50,252
-44,054
-40,726
-52,142
Tax Provision
0
0
0
0
0
Net Income Common Stockholders
-45,767
-50,252
-44,054
-40,726
-52,142
Diluted NI Available to Com Stockholders
-45,767
-50,252
-44,054
-40,726
-52,142
Basic EPS
-0.08
-0.11
-0.25
-0.26
-0.35
Diluted EPS
-0.08
-0.11
-0.25
-0.26
-0.35
Basic Average Shares
510,772.06
463,099.35
171,144.26
160,137.52
148,244.92
Diluted Average Shares
705,534.56
463,099.35
171,144.26
160,137.52
148,244.92
Total Operating Income as Reported
-45,996
-50,480
-44,176
-40,724
-51,233
Total Expenses
46,036
50,397
44,039
40,656
52,826
Net Income from Continuing & Discontinued Operation
-45,767
-50,252
-44,054
-40,726
-52,142
Normalized Income
-45,767
-50,252
-44,054
-40,726
-52,142
Interest Income
--
229
122
--
--
Interest Expense
--
--
--
2
1,859
Net Interest Income
230
229
122
-2
-1,859
EBIT
-45,913
-50,397
-44,039
-40,724
-50,283
EBITDA
-45,913
-50,397
-44,039
-40,724
-50,283
Net Income from Continuing Operation Net Minority Interest
-45,767
-50,252
-44,054
-40,726
-52,142
Normalized EBITDA
-45,913
-50,397
-44,039
-40,724
-50,283
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
0
0
0
0
0
12/31/2021 - 4/19/2017

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

688163.SS Shanghai Serum Bio-Technology Co., Ltd.
20.51
-2.29%
 
FLUI.ST Fluicell AB (publ)
11.00
-7.56%
 
NLSPW NLS Pharmaceutics AG
0.0190
-11.63%
 
EXPRS2.ST ExpreS2ion Biotech Holding AB (publ)
22.40
+3.23%
 
IVBXF Innovent Biologics, Inc.
10.08
+6.11%
 
GRTX Galera Therapeutics, Inc.
0.0259
+8.82%
 
HNSA.ST Hansa Biopharma AB (publ)
26.20
+2.34%
 
SVRA Savara Inc.
2.3300
-2.10%
 
EVAX Evaxion A/S
3.0200
+0.33%
 
ACOG Alpha Cognition Inc. Common Stock
9.02
-1.64%